- NSE
- DIVISLAB
- BSE
- 532488
- ISIN
- INE361B01024
DIVI S LABORATORIES
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹11,565.50
+₹1,245.00 (+12.06%)
NSE close ·
DIVI S LABORATORIES closed at ₹11,565.50 on 9 Nov 2026, up 12.06% on the day, and is up 73.75% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹5,821.00 to ₹11,565.50.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹3,07,028 Cr
- P/E (TTM)
- 91.3
- Industry P/E
- 35.5
- EPS (TTM)
- ₹126.73
- P/B
- 17.06
- Book value
- ₹677.93
- ROE
- 18.7%
- ROCE
- 24.8%
- Debt/equity
- 0.00
- Operating margin
- 33.3%
- Net margin
- 27.6%
- Dividend yield
- 0.26%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +20.37% | +17.85% |
| Net profit | +35.33% | +36.18% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹3,770 Cr | ₹1,127 Cr | +63.57% | ₹42.49 |
| Jun 2026 | ₹3,144 Cr | ₹902 Cr | +65.50% | ₹33.95 |
| Mar 2026 | ₹2,986 Cr | ₹751 Cr | +13.44% | ₹28.31 |
| Dec 2025 | ₹2,692 Cr | ₹583 Cr | −1.02% | ₹21.98 |
| Sep 2025 | ₹2,860 Cr | ₹689 Cr | +35.10% | ₹25.97 |
| Jun 2025 | ₹2,529 Cr | ₹545 Cr | +26.74% | ₹20.49 |
| Mar 2025 | ₹2,671 Cr | ₹662 Cr | +23.05% | ₹24.93 |
| Dec 2024 | ₹2,401 Cr | ₹589 Cr | +64.53% | ₹22.20 |
Armor risk check
DIVI S LABORATORIES moves about 1.8× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is DIVI S LABORATORIES's share price today?
DIVI S LABORATORIES (NSE: DIVISLAB) closed at ₹11,565.50 on 9 Nov 2026, up 12.06% from the previous close of ₹10,320.50. It traded between ₹11,071.00 and ₹11,824.00 that day.
What are DIVI S LABORATORIES's 52-week high and low?
Over the last 52 weeks DIVI S LABORATORIES traded between ₹5,647.50 and ₹11,824.00, adjusted for splits and bonuses.
What are DIVI S LABORATORIES's NSE symbol, BSE code and ISIN?
DIVI S LABORATORIES has NSE symbol DIVISLAB, BSE code 532488, ISIN INE361B01024.
How has DIVI S LABORATORIES performed over 1, 3 and 5 years?
DIVI S LABORATORIES's share price return: 1Y +73.75%, 3Y +48.97% a year, 5Y +18.49% a year. Dividends are not included.
Does DIVI S LABORATORIES pay a dividend?
Yes. DIVI S LABORATORIES's latest dividend went ex on 24 Jul 2026: Final · ₹30.00 per share. Dividends over the past year come to a yield of 0.26% at the latest close.
What is DIVI S LABORATORIES's P/E ratio?
DIVI S LABORATORIES's P/E ratio is 91.3: the ₹11,565.50 close on 9 Nov 2026 over trailing twelve-month EPS of ₹126.73 (consolidated, four quarters to 30 Sep 2026).
What is DIVI S LABORATORIES's market cap?
DIVI S LABORATORIES's market cap is ₹3,07,028 Cr at the close on 9 Nov 2026.
Which sector is DIVI S LABORATORIES in?
DIVI S LABORATORIES is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how DIVI S LABORATORIES fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app